because short-term infusions of intravenous calcitriol are capable of suppressing the secretion of parathyroid hormone in patients with uremia without causing hypercalcemia , we evaluated the effectiveness of long-term intermittent calcitriol infusions ( 1.0 to 2.5 micrograms three times weekly , during dialysis ) in treating severe osteitis fibrosa in 12 consecutive patients on hemodialysis whose disease was refractory to conventional therapy .
C0020437
hypercalcemia
C0006674
calcitriol